GlassScriptPhysician profile
Michael Tyler Booth
NPI 1811408313
$2,957.62
in general payments reported to CMS, 2019-2025
35 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,246 · 2022: $705 · 2023: $257 · 2024: $499 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,006.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $342.63 | 2021-2024 | |
| Depuy Synthes Sales INC. | $284.60 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $282.85 | 2021-2025 | Euflexxa |
| Radius Health, INC. | $218.82 | 2021-2022 | |
| Horizon Therapeutics Plc | $188.74 | 2021-2022 | |
| Vertos Medical, INC. | $155.83 | 2021-2024 | Mild Device Kit |
| Amgen INC. | $142.34 | 2022-2025 | Evenity, Prolia |
| Fidia Pharma USA INC. | $127.52 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $123.64 | 2021-2023 | |
| Pacira Therapeutics, INC. | $113.93 | 2021 | |
| Janssen Biotech, INC. | $108.27 | 2024-2025 | Tremfya |
| Globus Medical, INC. | $96.52 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $82.70 | 2021-2023 | Strensiq |
| Ucb, INC. | $79.87 | 2021-2024 | Cimzia, Bimzelx |
| Alvogen INC | $76.37 | 2023-2025 | Teriparatide |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $70.45 | 2024 | Physio-Stim |
| Kowa Pharmaceuticals America, INC. | $57.18 | 2022-2023 | Seglentis |
| Ultragenyx Pharmaceutical INC. | $37.23 | 2021 | |
| Boston Scientific Corporation | $35.64 | 2021 | |
| Heron Therapeutics, INC. | $33.78 | 2022 | |
| Dynasplint Systems INC. | $33.50 | 2023 | Dynasplint |
| Nalu Medical, INC. | $33.00 | 2024 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $32.47 | 2025 | |
| Bioventus LLC | $25.04 | 2022-2023 | Bonescalpel |
| Heraeus Medical, LLC. | $21.83 | 2021 | |
| Zimmer Biomet Holdings, INC. | $18.89 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $17.31 | 2024 | Caldolor |
| Molnlycke Health Care US, LLC | $16.59 | 2023 | Mepilex Border Post-Op Ag, Mepilex Border Post-Op |
| Sobi, INC | $16.54 | 2025 | |
| Invivyd INC | $15.88 | 2025 | Pemgarda |
| Kci USA, INC. | $15.75 | 2022 | |
| Fresenius Kabi USA, LLC | $14.59 | 2023 | Sodium Chloride |
| Endo Pharmaceuticals INC. | $14.57 | 2022 | |
| Smith+Nephew, INC. | $12.35 | 2021 | |
| Royal Biologics, INC. | $10.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Booth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.